News Fulgent Genetics, Inc.

Equities

FLGT

US3596641098

Real-time Estimate Cboe BZX Other stock markets 09:55:18 2024-06-10 am EDT			5-day change	1st Jan Change
19.84 ^USD	-2.27%		-4.70%	-31.20%

May. 03	Transcript : Fulgent Genetics, Inc., Q1 2024 Earnings Call, May 03, 2024
May. 03	Earnings Flash (FLGT) FULGENT GENETICS Posts Q1 Revenue $64.5M	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Fulgent Data at ASCO 2024 Highlights Antitumor Activity from Lead Therapeutic Oncology Candidate, FID-007, in Head and Neck Cancer	Jun. 03	BU
Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2024 Annual Meeting	May. 24	BU
Moffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer Therapeutics	May. 14	BU
Fulgent Reports First Quarter 2024 Financial Results	May. 06	AQ
Transcript : Fulgent Genetics, Inc., Q1 2024 Earnings Call, May 03, 2024	May. 03
Earnings Flash (FLGT) FULGENT GENETICS Posts Q1 Revenue $64.5M	May. 03	MT
Fulgent Genetics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 03	CI
Fulgent Reports First Quarter 2024 Financial Results	May. 03	BU
Fulgent Genetics, Inc. Reiterates Earnings Guidance for the Year 2024	May. 03	CI
Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024	Apr. 11	BU
Piper Sandler Adjusts Price Target on Fulgent Genetics to $25 From $28, Maintains Neutral Rating	Mar. 06	MT
UBS Adjusts Fulgent Genetics Price Target to $25 From $35, Maintains Neutral Rating	Feb. 29	MT
Tranche Update on Fulgent Genetics, Inc.'s Equity Buyback Plan announced on March 8, 2022.	Feb. 28	CI
Fulgent Genetics, Inc. Provides Earnings Guidance for the Year 2024	Feb. 28	CI
Transcript : Fulgent Genetics, Inc., Q4 2023 Earnings Call, Feb 28, 2024	Feb. 28
Fulgent Genetics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 28	CI
Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results	Feb. 28	BU
Earnings Flash (FLGT) FULGENT GENETICS Reports Q4 Revenue $70.5M	Feb. 28	MT
Earnings Flash (FLGT) FULGENT GENETICS Reports Q4 EPS $0.28	Feb. 28	MT
Fulgent Genetics to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024	Feb. 13	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Fulgent Genetics, Inc.

Equities

FLGT

US3596641098

Summary

Filters